Tower Research Capital (TRC)’s T2 Biosystems, Inc TTOO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,304
| Closed | -$2.23K | – | 6055 |
|
|
2024
Q4 | $2.23K | Buy |
5,304
+2,905
| +121% | +$2.43K | ﹤0.01% | 4883 |
|
|
2024
Q3 | $4.73K | Sell |
2,399
-5,268
| -69% | -$20K | ﹤0.01% | 4439 |
|
|
2024
Q2 | $40.9K | Buy |
7,667
+4,809
| +168% | +$20.1K | ﹤0.01% | 3247 |
|
|
2024
Q1 | $8.57K | Buy |
2,858
+819
| +40% | +$3.83K | ﹤0.01% | 3996 |
|
|
2023
Q4 | $12.8K | Buy |
2,039
+2,036
| +67,867% | +$15.6K | ﹤0.01% | 4016 |
|
|
2023
Q3 | $66 | Sell |
3
-63
| -95% | -$1.64K | ﹤0.01% | 5762 |
|
|
2023
Q2 | $466 | Sell |
66
-1
| -1% | -$23 | ﹤0.01% | 5634 |
|
|
2023
Q1 | $3K | Buy |
67
+17
| +34% | +$1.86K | ﹤0.01% | 5274 |
|
|
2022
Q4 | $7K | Buy |
+50
| New | +$10.3K | ﹤0.01% | 4648 |
|
|
2022
Q3 | – | Sell |
-18
| Closed | -$15K | – | 6639 |
|
|
2022
Q2 | $15K | Buy |
18
+16
| +800% | +$23.7K | ﹤0.01% | 4107 |
|
|
2022
Q1 | $6K | Hold |
2
| – | – | ﹤0.01% | 4958 |
|
|
2021
Q4 | $4K | Buy |
+2
| New | +$6.96K | ﹤0.01% | 5369 |
|
|
2021
Q3 | – | Sell |
-1
| Closed | -$5.03K | – | 5327 |
|
|
2021
Q2 | $3K | Buy |
+1
| New | +$6.46K | ﹤0.01% | 4974 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 5236 |
|
|
2020
Q3 | – | Sell |
-8
| Closed | -$48K | – | 5175 |
|
|
2020
Q2 | $48K | Buy |
+8
| New | +$34K | ﹤0.01% | 3089 |
|
|
2020
Q1 | – | Sell |
-7
| Closed | -$39K | – | 4110 |
|
|
2019
Q4 | $39K | Buy |
+7
| New | +$66.2K | ﹤0.01% | 1500 |
|
|
2019
Q3 | – | Sell |
-4
| Closed | -$38K | – | 4618 |
|
|
2019
Q2 | $38K | Buy |
+4
| New | +$46.9K | ﹤0.01% | 1776 |
|
|
2019
Q1 | – | Sell |
-2
| Closed | -$34K | – | 3220 |
|
|
2018
Q4 | $25K | Buy |
+2
| New | +$47K | ﹤0.01% | 1773 |
|
|
2017
Q4 | – | Sell |
-1
| Closed | -$12K | – | 4147 |
|
|
2017
Q3 | $12K | Hold |
1
| – | – | ﹤0.01% | 3010 |
|
|
2017
Q2 | $13K | Buy |
+1
| New | +$20K | ﹤0.01% | 1470 |
|
|
2017
Q1 | – | Hold |
0
| – | -$1K | – | 4087 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 3682 |
|
|
2016
Q3 | – | Sell |
-1
| Closed | -$30K | – | 4634 |
|
|
2016
Q2 | $30K | Buy |
+1
| New | +$45.1K | ﹤0.01% | 1939 |
|
|
2015
Q4 | – | Sell |
-1
| Closed | -$22K | – | 5179 |
|
|
2015
Q3 | $22K | Buy |
+1
| New | +$66.4K | ﹤0.01% | 1660 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 5166 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 2592 |
|
|
2014
Q4 | – | Hold |
0
| – | -$8K | – | 4827 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 3016 |
|
Tower Research Capital (TRC)'s TTOO Position: Q1 2025 in Review
Tower Research Capital (TRC) sold out of T2 Biosystems, Inc (TTOO) in Q1 2025, closing a stake of 5,304 shares — an estimated $2.23K sold.
Tower Research Capital (TRC) first reported a position in TTOO in Q3 2015 and held it in 21 quarters. The position peaked at $48K in Q2 2020. 2 funds tracked by Wall St. Rank hold TTOO as of Q1 2025.
- Tower Research Capital (TRC) reported no remaining T2 Biosystems, Inc position as of Q1 2025 after selling out during the quarter.
- Tower Research Capital (TRC) sold 5,304 T2 Biosystems, Inc shares in Q1 2025, an estimated $2.23K.
- Tower Research Capital (TRC) first reported a position in T2 Biosystems, Inc in Q3 2015 and held it in 21 quarters.
- Tower Research Capital (TRC)'s T2 Biosystems, Inc position peaked at $48K in Q2 2020.
- 2 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q1 2025.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2025, filed 15 May 2025.